Drug targeting with polyalkylcyanoacrylate nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani

REFERENCES

• Alving, C. R., Sterck, E. A., Hanson, W. L., Loizeaux, P. S. & Chapman, W. L. Jr. (1978). Improved therapy of experimental leishmaniasis by use of a liposome-encapsulated antimonial drug. Life Sciences, 22, 1021–1026.
   PubMed Web of Science ®Google Scholar
• Artursson, P., Arro, E., Edman, P., Ericsson, J. L. E. & Sjöholm, I. (1987). Biodegradable microspheres V: stimulation of macrophages with microparticles made of various polysaccharides. Journal of Pharmaceutical Sciences, 76, 127–133.
   PubMed Web of Science ®Google Scholar
• Baillie, A. J., Coombs, G. G., Dolan, T. F. & Laurie, J. (1986). Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug sodium stibogluconate. Journal of Pharmacy and Pharmacology, 38, 502–505.
   PubMed Web of Science ®Google Scholar
• Berman, J. D. (1985). Experimental chemotherapy of leishmaniasis—a critical review. In Leishmaniasis, eds. Chang, K.-P. & Bray, R., S. pp. 111–138. Amsterdam: Elsevier Science.
   Google Scholar
• Berman, J. D., Gallalee, J. V., Williams, J. S. & Hockmeyer, W. D. (1986). Activity of pentamidine-containing human red ghost cells against visceral leishmaniasis in the hamster. American Journal of Tropical Medicine and Hygiene, 35, 297–302.
   PubMed Web of Science ®Google Scholar
• Brun, R. & Schönenberger, M. (1979). Cultivation and in vitro cloning of procyclic culture forms of Trypanosoma brucei in a semi-defined medium. Acta Tropica, 36, 289–292.
   PubMed Web of Science ®Google Scholar
• Chang, K.-P. (1980). Human cutaneous Leishmania in a mouse macrophage line: propagation and isolation of intracellular parasites. Science, 209, 1240–1242.
   PubMed Web of Science ®Google Scholar
• Couvreur, P. (1988). Polyalkylcyanoacrylates as colloidal drug carriers. CRC Critical Reviews in Therapeutic Drug Carrier Systems, 5, 1–20.
   PubMed Web of Science ®Google Scholar
• De Duve, C. (1975). Exploring cells with a centrifuge. Science, 189, 186–194.
   PubMed Web of Science ®Google Scholar
• Fouarge, M., Dewulf, M., Couvreur, P., Roland, M. & Vranckz, H. (1989). Development of dehydroemetine nanoparticles for the treatment of visceral leishmaniasis. Journal of Microencapsulation, 6, 29–34.
   PubMed Web of Science ®Google Scholar
• Fouarge, M., Osuna, A., Couvreur, P., Roland, M. & Vranckx, H. (1987). Efficacité thérapeutique d'une forme vectoriseé de déhydroémétine dans le traitement de la leishmaniose viscérale. 47th International Congress of Pharmaceutical Sciences of FIP, 31 August–4 September, 1987.
   Google Scholar
• Gaspar, R., Préat, V., Opperdoes, F. & Roland, M. (1992). Macrophage activation by polymeric nanoparticles of polyalkylcyanoacrylates: activity against intracellular Leishmania donovani associated with hydrogen peroxide production. Pharmaceutical Research, in press.
   Google Scholar
• Gaspar, R., Préat, V. & Roland, M. (1991). Nanoparticles of polyisohexylcyanoacrylate (P.I.H.C.A.) as carriers of primaquine: formulation, physico-chemical characterization and acute toxicity. International Journal of Pharmaceutics, 68, 111–119.
   Web of Science ®Google Scholar
• Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D. & Speiser, P. (1983). Pharmacokinetics and distribution of a biodegradable drug-carrier. International Journal of Pharmaceutics, 15, 335–345.
   Web of Science ®Google Scholar
• Hart, D. T. (1987). Leishmania host-parasite interactions: The development of chemotherapeutic targets and specific drug delivery systems. I. Lipoprotein-mediated antileishmanial chemotherapy. In Host-Parasite Cellular and Molecular Interactions in Protozoal Infections, eds. Chang, K.-P. & Snary, D. pp. 203–211. Berlin: Springer Verlag.
   Google Scholar
• Hart, D. T., Lauwers, W. J., Willemsems, G., Bossche, H. V. & Opperdoes, F. R. (1989). Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana Mexicana-infected macrophages. Molecular and Biochemical Parasitology, 33, 123–134.
   PubMed Web of Science ®Google Scholar
• Kante, B., Couvreur, P., Dubois-Krak, G., De Meester, C., Guiot, P., Roiland, M., Mercier, M. & Speiser, P. (1982). Toxicity of polyalkylcyanoacrylate nanoparticles. I: Free nanoparticles. Journal of Pharmaceutical Sciences, 71, 786–790.
   PubMed Web of Science ®Google Scholar
• Laakso, T., Stjárnkvist, P. & Sjöholm, I. (1987). Biodegradable microspheres VI: Lysosomal release of covalently-bound antiparasitic drugs from starch microparticles. Journal of Pharmaceutical Sciences, 76, 134–140.
   PubMed Web of Science ®Google Scholar
• Lenaerts, V. (1984). Contribution à l'étude de dégradation et de distribution des nanoparticles de polycyanoacrylate d'alkyle. Thesis, Université Catholique de Louvain, Bruxelles.
   Google Scholar
• Lenaerts, V., Couvreur, P., Christianes-Leyh, D., Joiris, E., Roland, M., Rollman, B. & Speiser, P. (1984a). Degradation of polyisobutylcyanoacrylate nanoparticles. Biomaterials, 5, 65–68.
   PubMed Web of Science ®Google Scholar
• Lenaerts, V., Nagelkerke, J. F., Van Berkel, T. J. C., Couvreur, P., Grislain, L., Roland, M. & Speiser, P. (1984b). In vivo uptake of polyisobutylcyanoacrylate nanoparticles by rat liver, Küppfer, endothelial and parenchymal cells. Journal of Pharmaceutical Sciences, 73, 980–982.
   PubMed Web of Science ®Google Scholar
• Lherm, C., Couvreur, P., Loiseau, P., Bories, C. & Gayral, P. (1986). Unloaded polyisobutylcyanoacrylate nanoparticles efficiency against bloodstream trypanosomes. Journal of Pharmacy and Pharmacology, 39, 650–652.
   Web of Science ®Google Scholar
• Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. (1951). Protein measurements with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• McChesney, J. D., Baker, J. K., Clark, A. M. & Hufford, C. D. (1987). Primaquine: studies of mammalian metabolism. In Primaquine: Pharmacokinetics, Metabolism, Toxicity and Activity, eds. Wernsdorfer, W. I. & Triegg, P. I. pp. 3–26. New York: John Wiley & Sons.
   Google Scholar
• Murray, H. W. (1981). Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates. Journal of Experimental Medicine, 153, 1690–1695.
   PubMed Web of Science ®Google Scholar
• Neal, R. (1987). Experimental chemotherapy. In The Leishmaniases in Biology and Medicine, Vol. 2, Clinical Aspects and Control, eds. Peters, W. & Killick-Kendrick, R. pp. 793–845. London: Academic Press.
   Google Scholar
• Peters, W., Trotter, E. R. & Robinson, B. L. (1980). The experimental chemotherapy of leishmaniasis V: the activity of potential leishmanicides against ‘L. infantum LV9’ in NMRI mice. Annals of Tropical Medicine and Parasitology, 74, 289–298.
   PubMed Web of Science ®Google Scholar
• Stjärnkvist, P., Artursson, P., Brunmark, A., Laakso, T. & Sjöholm, I. (1987). Biodegradable microspheres VIII. Killing of Leishmania donovani in cultured macrophages by microparticle-bound primaquine. International Journal of Pharmaceutics, 40, 214–222.
   Web of Science ®Google Scholar
• Tarlov, A. R., Brewer, G. J., Carson, P. E. & Alving, A. S. (1962). Primaquine sensitivity. Glucose-6-phosphate-dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. Archives of Internal Medicine, 109, 209–234.
   PubMed Web of Science ®Google Scholar
• Verdun, C., Couvreur, P., Vranckx, H., Lenaerts, V. & Roland, M. (1986). Development of a nanoparticle controlled-release formulation for human use Journal of Controlled Release, 3, 205–210.
   Google Scholar
• Webster, L. T. (1985). Drugs in the chemotherapy of protozoal infections: Malaria. In The Pharmacological Basis of Therapeutics, 7th edition, eds. Gilman, A. G., Goodman, L., S., Rail, T. W. & Murad, F. pp. 1029–1048. New York: Macmillan.
   Google Scholar